This episode features Dr. Anna Casu, Associate Investigator at Translational Research Institute – AdventHealth. Here, she discusses the work AdventHealth is doing with TZIELD, the first FDA approved ...
Satralizumab is safe and effective for patients with myelin oligodendrocyte glycoprotein antibody-associated disease, the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results